Back to Search
JOSEPH PREY, PHARMD
PHARMD
Pharmacist
NPI: 1306569975Individual
Specialties, Licenses & Credentials
Research & Publications (6)
Capecitabine, oxaliplatin and radiotherapy: a phase IB neoadjuvant study for esophageal cancer with gene expression analysis.
PMID 19235592·Cancer Invest·2009
3-trial
A Phase I and pharmacokinetic study of selenomethionine in combination with a fixed dose of irinotecan in solid tumors.
PMID 17989978·Cancer Chemother Pharmacol·2008
3-trial
Efficacy of increasing the therapeutic index of irinotecan, plasma and tissue selenium concentrations is methylselenocysteine dose dependent.
PMID 17239826·Biochem Pharmacol·2007
7-preclinical
A phase I and pharmacokinetic study of fixed-dose selenomethionine and irinotecan in solid tumors.
PMID 16489079·Clin Cancer Res·2006
3-trial
Pharmacokinetic measurements of IDN 5390 using electrospray ionization tandem mass spectrometry: structure characterization and quantification in dog plasma.
PMID 16299696·Rapid Commun Mass Spectrom·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 7915 FLORENCE AVE
DOWNEY, CA 90240 - Phone
- (562) 927-4747
Quick Facts
- NPI
- 1306569975
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 6
Are you this provider?
Claim Your Profile